These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21147447)

  • 1. Eisenmenger syndrome due to a large ductus arteriosus.
    Labombarda F; Kerros H; Grollier G
    Arch Cardiovasc Dis; 2010; 103(11-12):623-5. PubMed ID: 21147447
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pulmonary arterial hypertension in congenital heart defects with shunt: a heterogeneous and complex constellation].
    Zimmermann R; Schranz D; Ewert P; Kaemmerer H
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1244-6. PubMed ID: 23720181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features of adult patients with Eisenmenger syndrome associated with different types of congenital heart disease].
    Chen G; He JG; Liu ZH; Gu Q; Ni XH; Zhao ZH; Xiong CM
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(20):1546-9. PubMed ID: 24028720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eisenmenger syndrome with unrepaired patent ductus arteriosus.
    Ryan JJ; Suksaranjit P; Hatton N; Bull DA; Wilson BD
    Circulation; 2015 Apr; 131(16):e409-11. PubMed ID: 25901073
    [No Abstract]   [Full Text] [Related]  

  • 5. Eisenmenger syndrome in an adult patient with a large patent ductus arteriosus.
    Dimopoulos K
    Eur Respir Rev; 2013 Dec; 22(130):558-64. PubMed ID: 24293472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease.
    Diller GP; Dimopoulos K; Kaya MG; Harries C; Uebing A; Li W; Koltsida E; Gibbs JS; Gatzoulis MA
    Heart; 2007 Aug; 93(8):974-6. PubMed ID: 17639112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary hypertension--hemodynamic and clinical examples of some congenital heart defect].
    Keck EW
    Med Klin; 1966 Mar; 61(9):325-30. PubMed ID: 5986157
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down's syndrome.
    Duffels MG; Vis JC; van Loon RL; Nieuwkerk PT; van Dijk AP; Hoendermis ES; de Bruin-Bon RH; Bouma BJ; Bresser P; Berger RM; Mulder BJ
    Am J Cardiol; 2009 May; 103(9):1309-15. PubMed ID: 19406277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of bosentan in adults with simple and complex Eisenmenger's syndrome.
    Williams R; Houser L; Miner P; Aboulhosn J
    Congenit Heart Dis; 2012; 7(1):12-5. PubMed ID: 22188797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition.
    Duffels M; van Loon L; Berger R; Boonstra A; Vonk-Noordegraaf A; Mulder B
    Congenit Heart Dis; 2007; 2(4):242-9. PubMed ID: 18377475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
    Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.
    Durongpisitkul K; Jakrapanichakul D; Sompradikul S
    J Med Assoc Thai; 2008 Feb; 91(2):196-202. PubMed ID: 18389984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eisenmenger syndrome in the adult--experience with new drugs for the treatment of pulmonary hypertension.
    Agapito AF; Sousa L; Oliveira JA; Feliciano J; Cacela D; Quininha J
    Rev Port Cardiol; 2005 Mar; 24(3):421-31. PubMed ID: 15929625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic methods used in patients with Eisenmenger syndrome.
    Trojnarska O; Plaskota K
    Cardiol J; 2009; 16(6):500-6. PubMed ID: 19950085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
    Mehta PK; Simpson L; Lee EK; Lyle TA; McConnell ME; Book WM
    Tex Heart Inst J; 2008; 35(3):256-61. PubMed ID: 18941642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.
    Berger RM; Beghetti M; Galiè N; Gatzoulis MA; Granton J; Lauer A; Chiossi E; Landzberg M
    Int J Cardiol; 2010 Oct; 144(3):373-8. PubMed ID: 19464064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy.
    D'Alto M; Romeo E; Argiento P; Santoro G; Sarubbi B; Gaio G; Mélot C; Russo MG; Naeije R; Calabrò R
    Heart; 2010 Sep; 96(18):1475-9. PubMed ID: 20668108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bosentan treatment for pulmonary arterial hypertension due to patent ductus arteriosus and Down's syndrome in an infant.
    He J; Ren Y; Chen Y; Feng Y
    Int J Cardiol; 2014 Oct; 176(3):e117-8. PubMed ID: 25129297
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent ductus arteriosus.
    Schneider DJ; Moore JW
    Circulation; 2006 Oct; 114(17):1873-82. PubMed ID: 17060397
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.
    Hopkins WE; Ochoa LL; Richardson GW; Trulock EP
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):100-5. PubMed ID: 8820089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.